PSOH gives its congratulations to Edward Balaban, DO, FACP, FASCO and Marilyn Heine, MD for being awarded at the ASCO Advocacy Summit.
Edward Balaban, DO , FACP, FASCO Named Advocate of the Year by the Association for Clinical Oncology
The Association for Clinical Oncology (ASCO) named Edward Balaban, DO, FACP, FASCO Advocate of the Year during the 2022 ASCO Advocacy Summit in April.
In 2021, Dr. Balaban went above and beyond advocating on behalf of cancer care professionals and their patients. From sending ACT Network letters to his lawmakers, participating in the 2021 Advocacy Summit, attending agency meetings with the Government Relations Committee, or serving on ASCO’s delegation to the American Medical Association House of Delegates, Dr. Balaban made cancer care advocacy a priority throughout 2021. Dr. Balaban’s dedication to ensuring patients with cancer receive the best possible care is truly inspiring. Congratulations!
Marilyn Heine, MD Named Advocacy Champion by the Association for Clinical Oncology
The Association for Clinical Oncology (ASCO) named Marilyn Heine, MDas an Advocacy Champion during the 2022 ASCO Advocacy Summit in April. Advocacy Champions are ASCO volunteers who have made meaningful contributions to the Association’s advocacy activities throughout the year to ensure that every patient with cancer has access to high-quality, equitable cancer care, no matter who they are or where they live. Advocates speak with federal lawmakers and agencies, send personalized letters to Members of Congress through ASCO’s ACT Network, engage with state lawmakers on policy priorities at the state-level, and host site visits for lawmakers in their home states and districts. Congratulations!
Read more about the advocacy activities.Everyday Use of AI and ChatGPT in Oncology Practice
July 5th 2023In an interview with Targeted Oncology, Arturo Loaiza-Bonilla, MD, MSEd, discussed the growing use of artificial intelligence in oncology practices. Loaiza-Bonilla is a medical oncologist and cofounder of Massive Bio, a company that uses AI to connect oncologists and patients with cancer to clinical trials of novel treatments.
Read More
Esophageal Cancer Awareness Month: Paradigm Shifts in Targetable Disease
April 17th 2023In an interview with Targeted Oncology for Esophageal Cancer Awareness Month, Arturo Loaiza-Bonilla, MD, MSEd, discussed the pressing need to keep up with the developments in targeted therapies for esophageal and GEJ cancers.
Read More
The Impact of CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma
March 30th 2021The paradigm for management of relapsed myeloma is evolving rapidly with a plethora of treatment options based on results of clinical trials. One explosive area of scientific and clinical research is the investigation of chimeric antigen receptor T-cell therapy.
Read More